Hillary A. Coleman

We advised Signify Health on its IPO and NYSE listing

We advised the initial purchaser on the high-yield notes offering

We advised the initial purchasers on the high-yield notes offering

We advised the initial purchaser in connection with the Rule144A / Regulation S offering

Davis Polk advised the initial purchaser in connection with a Rule 144A offering by MicroStrategy Incorporated of $650 million aggregate principal amount of its 0.750% convertible…

Davis Polk advised Auna S.A.A. in connection with its Rule 144A/Regulation S offering of $300 million aggregate principal amount of its 6.500% senior notes due 2025. The notes are…

Davis Polk advised Arcos Dorados Holdings Inc. in connection with the exchange of approximately $131.5 million aggregate principal amount of its 6.625% senior notes due 2023 for its 5.785%…

Davis Polk advised Grayscale Investments, LLC, as sponsor, in connection with the registration of the common units of fractional undivided beneficial interest (“Shares”) of Grayscale…

Davis Polk advised the initial purchasers on a Rule 144A/Regulation S offering by PM General Purchaser LLC of $600 million aggregate principal amount of its 9.500% senior secured notes…

Davis Polk advised Nuvei Corporation in connection with its initial public offering of 30,961,539 subordinate voting shares for an aggregate amount of approximately $805 million. The…